Agilon Health (NYSE:AGL) Stock Price Down 10.1% – Here’s Why

Agilon Health, Inc. (NYSE:AGL)’s share price was down 10.1% during mid-day trading on Thursday . The stock traded as low as $95.00 and last traded at $96.15. 51,126 shares were traded during trading, a decline of 85% from the average daily volume of 349,669 shares. The stock had previously closed at $106.96.

Analyst Ratings Changes

A number of research firms have recently weighed in on AGL. Jefferies Financial Group raised shares of Agilon Health from a “hold” rating to a “buy” rating and boosted their price objective for the company from $27.50 to $48.00 in a research report on Thursday, May 7th. JPMorgan Chase & Co. lowered shares of Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 target price on the stock. in a research report on Monday, May 4th. Benchmark reaffirmed a “buy” rating and issued a $95.00 target price (up from $13.00) on shares of Agilon Health in a research note on Thursday, May 21st. Robert W. Baird boosted their price target on Agilon Health from $20.00 to $35.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Finally, TD Cowen reissued a “hold” rating and set a $55.00 price target (up from $17.00) on shares of Agilon Health in a research note on Monday, May 11th. Five equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $58.73.

Agilon Health Trading Up 9.0%

The business’s fifty day moving average is $75.82 and its 200-day moving average is $37.30. The stock has a market capitalization of $1.95 billion, a PE ratio of -5.42 and a beta of 3.02. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.08.

Agilon Health (NYSE:AGL) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $1.80 EPS for the quarter, topping the consensus estimate of $1.04 by $0.76. The firm had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.38 billion. Agilon Health had a negative net margin of 6.09% and a negative return on equity of 146.03%. As a group, analysts anticipate that Agilon Health, Inc. will post -3.5 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the company. LPL Financial LLC grew its position in Agilon Health by 213.4% during the fourth quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock valued at $30,000 after acquiring an additional 30,000 shares during the period. Krilogy Financial LLC acquired a new stake in Agilon Health during the fourth quarter worth about $34,000. CIBC Bancorp USA Inc. purchased a new position in shares of Agilon Health in the 3rd quarter worth about $34,000. Merit Financial Group LLC purchased a new position in shares of Agilon Health in the 4th quarter worth about $35,000. Finally, Symphony Financial Services Inc. lifted its stake in shares of Agilon Health by 51.6% in the 3rd quarter. Symphony Financial Services Inc. now owns 47,000 shares of the company’s stock valued at $48,000 after purchasing an additional 16,000 shares in the last quarter.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.